| Literature DB >> 32764733 |
Georgina Donati1, Rachael Davis2, Gillian S Forrester3.
Abstract
Cerebral lateralisation of function is common characteristic across vertebrate species and is positively associated with fitness of the organism, in humans we hypothesise that it is associated with cognitive fitness. This investigation evaluated the early development of lateralised gaze behaviour for face stimuli in infants at high and low risk for autism from the British Autism Sibling Infant Study (BASIS). The BASIS cohort includes a low risk group and three high-risk groups who at age 3 were developing (i) typically, (ii) atypically or (iii) had received a diagnosis for ASD. Using eye-tracking data derived from a face pop-out task at 6 and 14 months of age, all non-ASD groups showed a bias for stimuli on the left at both timepoints. At 6 months the ASD group demonstrated a preference for stimuli on the right and were slower than their neurotypical counterparts to look at faces on the left. However, by 14 months these differences disappear. Longitudinal associations between lateral looking behaviour at 6 months and language and motor ability at 14 months were also found. Results suggest that infants who go on to be diagnosed with autism exhibit early differences in gaze behaviour that may be associated with subsequent cognitive outcomes.Entities:
Mesh:
Year: 2020 PMID: 32764733 PMCID: PMC7411063 DOI: 10.1038/s41598-020-69898-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Number of observations looking left and right at faces and non-faces at 6 and 14 months of age for each of the four groups. Each line shows the findings for each group. Standard deviations can be found in Table 1.
Descriptive Statistics of the eight measures created from the Face Pop-Out task and used in the subsequent analysis.
| LR typical | HR typical | HR atypical | HR ASD | |||
|---|---|---|---|---|---|---|
| Observation Scoresa | 6 months | Left face | 5.23 (2.82) | 5.13 (3.16) | 6.33 (1.90) | 4.89 (3.29) |
| Right face | 4.66 (3.18) | 4.28 (3.14) | 5.61 (3.09) | 6.41 (2.51) | ||
| Left non-face | 2.88 (2.13) | 2.70 (2.19) | 3.23 (2.05) | 2.06 (2.20) | ||
| Right non-face | 2.16 (2.03) | 1.28 (1.89) | 2.46 (1.95) | 3.63 (1.97) | ||
| 14 months | Left face | 5.32 (2.94) | 5.44 (3.55) | 7.35 (2.90) | 5.67 (3.10) | |
| Right face | 4.68 (3.04) | 5.36 (3.68) | 5.25 (3.73) | 4.92 (2.75) | ||
| Left non-face | 2.17 (2.02) | 1.36 (1.74) | 2.50 (1.89) | 2.04 (2.32) | ||
| Right non-face | 1.30 (1.67) | 1.24 (1.56) | 1.39 (1.76) | 1.23 (1.55) | ||
| Mean saccade scoresb | 6 months | Left face | − 0.30 (0.70) | 0.04 (0.88) | − 0.16 (0.72) | 0.97 (1.46) |
| Right face | 0.19 (1.23) | − 0.22 (0.70) | 0.20 (1.09) | − 0.30 (0.67) | ||
| Left non-face | − 0.01 (1.14) | 0.05 (0.99) | 0.12 (0.89) | − 0.19 (0.86) | ||
| Right non-face | − 0.05 (0.90) | 0.37 (1.15) | − 0.09 (0.83) | 0.12 (1.20) | ||
| 14 months | Left face | − 0.15 (1.20) | − 0.02 (0.44) | 0.06 (1.04) | 0.08 (0.76) | |
| Right face | 0.05 (1.12) | 0.00 (0.70) | 0.06 (1.37) | − 0.09 (0.76) | ||
| Left non-face | 0.18 (1.08) | 0.35 (1.11) | − 0.13 (0.90) | 0.25 (1.05) | ||
| Right non-face | 0.38 (1.14) | − 0.04 (0.86) | 0.34 (1.15) | 0.76 (1.28) | ||
aThese are rate scores (100/possible trials*observed trials) and then a square root transformation is applied. b These scores have been standardised. LR = low risk, HR = high risk.
Figure 2Saccade speed for looking left and right at faces and non-faces. Graphs created with the pooled means of all imputed datasets. Each line shows the findings for each group. Pooled standard deviations can be found in Table 1.
Proportion of missing saccade time scores relative to sample size in each variable for the entire sample at 6 months and 14 months.
| LR typical % | HR typical % | HR atypical % | HR ASD % | |||||
|---|---|---|---|---|---|---|---|---|
| 6 m | 14 m | 6 m | 14 m | 6 m | 14 m | 6 m | 14 m | |
| Left face | 18.2 | 18.0 | 20.8 | 25.0 | 0.0 | 8.3 | 23.5 | 17.6 |
| Right face | 27.3 | 22.0 | 29.2 | 25.0 | 16.7 | 25.0 | 5.9 | 17.6 |
| Left non-face | 27.3 | 42.0 | 29.2 | 58.3 | 25.0 | 33.3 | 47.1 | 52.9 |
| Right non-face | 40.9 | 60.0 | 62.5 | 58.3 | 33.3 | 58.3 | 17.6 | 58.8 |
Darker cells indicate a higher percentage of trials.
LR = low risk, HR = high risk.